arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Biomea Fusion, Inc.

BMEA

$1.26 0.00 (0.00%) at close

8 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Biomea Fusion, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $65.8M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -223.2% →

FCF / Share $-1.35 ↗

Trailing P/E —

Price / Book 3.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-61.80M

↑ +55.4% —

FCF / Share Free cash flow per share

$-1.35

↑ +59.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	69.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-11.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-22.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-60.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	55.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-18.1% Weak ↑ Weak Improving Year-over-year change in net income	-43.3% Weak ↑ Weak Improving Year-over-year change in net income	-96.9% Weak ↑ Weak Improving Year-over-year change in net income	-680.7% Weak Weak Year-over-year change in net income	-344.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	59.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-13.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	-35.2% Weak Weak Year-over-year change in free cash flow	-33.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-223.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-220.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-58.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-81.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	4495.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-142.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-180.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-64.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-209.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1494%)	-268.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1889%)	-69.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-562%)	-75.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-603%)	-23.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-255%)	-103.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-787%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-55.81M	$-58.28M	$-176.87M	$-111.90M	$-145.74M	$-61.70M	$-239.00K	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-1.18	$-3.83	$-3.44	$-2.80	$-1.74	—	—	—
Free Cash Flow per Share (USD)	$-1.35	$-3.33	$-2.93	$-2.17	$-1.62	—	—	—
Book Value per Share (USD)	$0.41	$1.42	$4.72	$3.67	$6.14	$0.43	—	—
Tangible Book Value per Share (USD)	$0.41	$1.42	$4.72	$3.67	$6.14	$0.43	—	—
Basic Weighted Avg Shares (shares)	52.23M	36.11M	34.11M	29.27M	23.86M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$46.95M	$46.66M	$156.32M	$98.72M	$171.92M	$60.60M	—	—
Total Equity (USD)	$29.55M	$51.57M	$169.24M	$108.54M	$178.78M	$5.17M	$-21.00K	$-263.00K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Depreciation Expense (USD)	$1.41M	$1.75M	$1.51M	$691.00K	$249.00K	$8.00K	$0.00	—
Net Income, GAAP (USD)	$-61.80M	$-138.43M	$-117.25M	$-81.83M	$-41.57M	$-5.32M	$-1.20M	—
Operating Cash Flow (USD)	$-70.37M	$-119.89M	$-96.59M	$-62.42M	$-35.44M	$-4.46M	$-1.28M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 27 quarters

Biomea Fusion, Inc.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BMEA with peers